In line with these findings of a negative Hh pathway regulation through DYRK1A, analysis of post-mortem brain samples from Down syndrome patients revealed a modest but significant reduction in expression of the Hh target genes GLI1 and PTCH2 in comparison with the normal brain33 (Supplementary Fig. 2h). The gene discussed is GLI1; the disease is Down syndrome.